Tag Archives: Xarelto

FDA Panel Once Again Rejects New Indication For J&J Drug

Posted on by

The FDA’s Cardiovascular and Renal Drugs Advisory Committee once again turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson’s Xarelto...
    






Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel

Posted on by

The third time may not be the charm. Twice before the FDA has turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson’s Xarelto (...
    






Pfizer’s Expiring Viagra Patent Adversely Affects Other Drugmakers Too

Posted on by

By David J. Phillips Looking ahead, the sex business isn’t expected to be as profitable as it once was for Pfizer Eli Lilly (LLY) and Bayer AG, manufacturers of Viagra, Cialis and Levitra,...